A large percentage of patients with gastrointestinal tumors (such as pancreatic, liver, gastric, colorectal tumors) and some other malignancies have been shown to have elevated serum CA 19-9 levels. Serum CA 19-9 levels may be useful for monitoring disease activity or predicting relapse following treatment.
Cancer, Gastrointestinal tumors
- Carbohydrate Antigen 19-9
pancreatic, liver, gastric, colorectal cancers